Literature DB >> 14517489

Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.

Analía Sánchez-Luceros1, Susana S Meschengieser, Carlos Marchese, Roberto Votta, Patricia Casais, Adriana I Woods, María V Nadal, María J Salviú, María A Lazzari.   

Abstract

Gestation is a challenge to haemostasis and it is associated with significant haemostatic changes. Several studies have evaluated von Willebrand factor in normal pregnancy, but none considered the personal history of bleeding. We studied a group of healthy non-bleeding women (184 pregnant, 64 puerperium, 37 non-pregnant) to evaluate normal ranges and their relationship to blood group and parity. The von Willebrand factor increased markedly from non-pregnant values up to the end of early puerperium (P < 0.0001), while factor VIII only showed a slight increase. Factor VIII and von Willebrand factor activity remained within the normal range for non-pregnant women. The return to non-pregnant factor levels occurred in late puerperium, later than previously reported. Only factor VIII was significantly lower in the O blood group (P = 0.035). As regards parity, there were no differences in factor VIII, von Willebrand factor antigen and von Willebrand factor ristocetin cofactor between primigravidae and multigravidae for any period studied (P = 0.888, 0.999, and 0.237, respectively). Our results provide reference ranges that may help to design a study in von Willebrand factor disease in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517489     DOI: 10.1097/00001721-200310000-00005

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Margaret V Ragni
Journal:  Blood Adv       Date:  2017-04-25

2.  Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome.

Authors:  Yoko Yoshida; Masanori Matsumoto; Hideo Yagi; Ayami Isonishi; Kazuya Sakai; Masaki Hayakawa; Yuji Hori; Toshiyuki Sado; Hiroshi Kobayashi; Yoshihiro Fujimura
Journal:  Blood Adv       Date:  2017-08-23

Review 3.  Von Willebrand Disease: Current Status of Diagnosis and Management.

Authors:  Angela C Weyand; Veronica H Flood
Journal:  Hematol Oncol Clin North Am       Date:  2021-08-13       Impact factor: 3.722

4.  The Effect of Von Willebrand Disease on Pregnancy, Delivery, and Postpartum Period: A Retrospective Observational Study.

Authors:  Mateja Sladič; Ivan Verdenik; Špela Smrkolj
Journal:  Medicina (Kaunas)       Date:  2022-06-07       Impact factor: 2.948

5.  High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.

Authors:  Martin Mohren; Kathleen Jentsch-Ullrich; Michael Koenigsmann; Siegfried Kropf; Enrico Schalk; Gerd Lutze
Journal:  Int J Hematol       Date:  2015-11-26       Impact factor: 2.490

Review 6.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

7.  Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy.

Authors:  Danielle N Drury-Stewart; Kerry W Lannert; Dominic W Chung; Gayle T Teramura; James C Zimring; Barbara A Konkle; Hilary S Gammill; Jill M Johnsen
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 8.  Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies.

Authors:  Flavia Franconi; Ilaria Campesi; Delia Colombo; Paola Antonini
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

9.  Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy.

Authors:  Scott Dunkley; Julie A Curtin; Anthony J Marren; Robert P Heavener; Simon McRae; Jennifer L Curnow
Journal:  Med J Aust       Date:  2019-03-29       Impact factor: 7.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.